XML 44 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statement of Changes in Equity - USD ($)
$ in Thousands
Aegis Transaction Agreement [Member]
Common Stock [Member]
Aegis Transaction Agreement [Member]
Additional Paid-in Capital [Member]
Aegis Transaction Agreement [Member]
Retained Earnings [Member]
Aegis Transaction Agreement [Member]
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Aegis Transaction Agreement [Member]
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]
Aegis Transaction Agreement [Member]
Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]
Aegis Transaction Agreement [Member]
Parent [Member]
Aegis Transaction Agreement [Member]
Noncontrolling Interest [Member]
Aegis Transaction Agreement [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]
Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]
Parent [Member]
Noncontrolling Interest [Member]
Total
Balance (in shares) at Mar. 31, 2018                   20,600,000                
Balance at Mar. 31, 2018                   $ 206 $ 153,704 $ (6,815) $ (110) $ 0 $ (292) $ 146,693 $ 47,452 $ 194,145
Issuance of common stock (in shares) 166,667                 453,264                
Issuance of common stock $ 2 $ 1,998 $ 0 $ 0 $ 0 $ 0 $ 2,000 $ 0 $ 2,000 $ 4 2,601 0 0 0 0 2,605 0 2,605
Purchase accounting entries due to the Aegis transactions (in shares)                   16,226,392                
Purchase accounting entries due to the Aegis transactions                   $ 162 108,340 0 0 0 0 108,502 0 108,502
Share-based compensation expenses                   0 674 0 0 0 0 674 0 674
Net income (loss)                   0 0 (24,312) 0 0 0 (24,312) 2,036 (22,276)
Dividend paid in cash                   0 0 0 0 0 0 0 (3,137) (3,137)
Other comprehensive loss for the period                   $ 0 0 0 (3,879) (15) (1,251) (5,145) (995) $ (6,140)
Balance (in shares) at Dec. 31, 2018                   37,446,323               37,446,323
Balance at Dec. 31, 2018                   $ 374 267,317 (31,127) (3,989) (15) (1,543) 231,017 45,356 $ 276,373
Issuance of common stock (in shares)                   1,079,313                
Issuance of common stock                   $ 11 6,699 0 0 0 0 6,710 0 6,710
Share-based compensation expenses                   0 1,516 0 0 0 0 1,516 0 1,516
Net income (loss)                   0 0 (15,018) 0 0 0 (15,018) 1,737 (13,281)
Other comprehensive loss for the period                   0 0 0 (579) 490 (386) (475) (354) (829)
Warrant contra expenses                   $ 0 1,295 0 0 0 0 1,295 0 $ 1,295
Balance (in shares) at Dec. 31, 2019                   38,525,636               38,525,636
Balance at Dec. 31, 2019                   $ 385 $ 276,827 $ (46,145) $ (4,568) $ 475 $ (1,929) $ 225,045 $ 46,739 $ 271,784